Original article| Volume 68, 104373, December 2022

Diagnosis concealment is prevalent in MS, and associated with diagnosis experience

Published:October 28, 2022DOI:


      • Approximately half of all individuals with multiple sclerosis conceal their diagnosis from others, particularly in professional spheres.
      • Individuals who had a more positive diagnosis experience are less likely to conceal their diagnosis later in the disease course.
      • Individuals with multiple sclerosis whose MS provider has discussed the issue of disclosure and concealment with them have less anticipation of negative consequences of disclosure.
      • Provider attention to the topic of diagnosis disclosure and concealment may be effective for reducing some of the stress individuals experience around this prevalent issue.



      Receiving a diagnosis of multiple sclerosis (MS) can be stressful; later, patients may conceal their diagnosis. Here, we aimed to (1) assess prevalence of disclosure and concealment behaviors, and (2) explore whether diagnosis experience is associated with later concealment and if MS provider engagement on this topic modifies concealment.


      In a survey-based study, MS patients completed DISCO-MS assessing disclosure and concealment and responded to questions about diagnosis experience and practitioner attention to disclosure. Frequency analysis and Pearson's correlations were used in exploratory analyses.


      428 adults with MS participated. 49% (N = 201) conceal their diagnosis. Higher education [t(405) = 3.66, p < 0.001], younger age (r = −0.15, p = 0.002), and shorter disease duration (r = −0.18, p = 0.010) were associated with higher concealment. 39% (N = 159) anticipate negative consequences of disclosure. Individuals reporting positive diagnosis experience (26%, N = 102) were less likely to conceal later in disease course compared to those with negative experience (34%, N = 136) [t(233) = 2.483, p = 0.014]. Patients whose MS providers discussed disclosure (23%, N = 73) anticipated less negative consequences of disclosure [t(323) = 2.475, p = 0.014].


      Diagnosis concealment is common in MS. Favorable diagnosis experience and provider attention to the topic of disclosure throughout the MS disease course may influence diagnosis concealment.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Aoun S.M.
        • Breen L.J.
        • Edis R.
        • et al.
        Breaking the news of a diagnosis of motor neurone disease: a national survey of neurologists’ perspectives.
        J. Neurol. Sci. 2016; 367 ([online serial]. J Neurol SciAccessed at) (Accessed May 20, 2022): 368-374
        • Aoun S.M.
        • Breen L.J.
        • Howting D.
        • et al.
        Receiving the news of a diagnosis of motor neuron disease: what does it take to make it better?.
        Amyotroph. Lateral Scler. Front. Degener. 2016; 17 ([online serial]. Amyotroph Lateral Scler Frontotemporal DegenerAccessed at:) (Accessed May 11, 2022): 168-178
        • Aoun S.M.
        • O'Brien M.R.
        • Breen L.J.
        • O'Connor M.
        The shock of diagnosis”: qualitative accounts from people with motor neurone disease reflecting the need for more person-centred care.
        J. Neurol. Sci. 2018; 387 ([online serial]. J Neurol SciAccessed at:) (Accessed May 20, 2022): 80-84
        • Barskova T.
        • Oesterreich R.
        Post-traumatic growth in people living with a serious medical condition and its relations to physical and mental health: a systematic review.
        Disabil. Rehabil. 2009; 31 ([online serial]. Disabil RehabilAccessed at:) (Accessed March 3, 2022): 1709-1733
        • Bornstein P.
        • Clayton P.
        The anniversary reaction. - PsycNET.
        Dis. Nerv. Syst. 1972; 33 ([online serial]Accessed at:) (Accessed April 26, 2022): 470-472
        • Braveman P.
        • Gottlieb L.
        The social determinants of health: it's time to consider the causes of the causes.
        Public Health Rep. 2014; 129: 19
        • Chalfant A.M.
        • Bryant R.A.
        • Fulcher G.
        Posttraumatic stress disorder following diagnosis of multiple sclerosis.
        J. Trauma. Stress. 2004; 17 ([online serial]. J Trauma StressAccessed at:) (Accessed March 4, 2022): 423-428
        • Cook J.E.
        • Germano A.L.
        • Stadler G.
        An exploratory investigation of social stigma and concealment in patients with multiple sclerosis.
        Int. J. MS Care. 2016; 18 ([online serial]. Consortium of Multiple SclerosisAccessed at) (Accessed March 16, 2021): 78-84
        • Gardner R.S.
        • Mainetti M.
        • Ascoli G.A.
        Older adults report moderately more detailed autobiographical memories.
        Front. Psychol. 2015; 6 ([online serial]. Frontiers Media S.AAccessed at:) (Accessed September 19, 2022): 631
        • Giordano A.
        • Granella F.
        • Lugaresi A.
        • et al.
        Anxiety and depression in multiple sclerosis patients around diagnosis.
        J. Neurol. Sci. 2011; 307: 86-91
        • Giordano A.
        • Lugaresi A.
        • Confalonieri P.
        • et al.
        Implementation of the “Sapere Migliora” information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial.
        Mult. Scler. 2014; 20 ([online serial]. Mult SclerAccessed at:) (Accessed April 27, 2022): 1234-1243
        • Heesen C.
        • Kolbeck J.
        • Gold S.M.
        • Schulz H.
        • Schulz K.H.
        Delivering the diagnosis of MS–results of a survey among patients and neurologists.
        Acta Neurol. Scand. 2003; 107 ([online serial]. Acta Neurol ScandAccessed at:) (Accessed April 27, 2022): 363-368
        • Isaksson A.K.
        • Ahlström G.
        From symptom to diagnosis: illness experiences of multiple sclerosis patients.
        J. Neurosci. Nurs. 2006; 38 ([online serial]. J Neurosci NursAccessed at) (Accessed April 27, 2022): 229-237
        • Janssens A.
        • Van Doorn P.A.
        • De Boer J.B.
        • Van Der Meché F.G.A.
        • Passchier J.
        • Hintzen R.Q.
        Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners.
        Acta Neurol. Scand. 2003; 108 ([online serial]. Acta Neurol ScandAccessed at) (Accessed April 27, 2022): 389-395
        • Johnson J.
        On receiving the diagnosis of multiple sclerosis: managing the transition.
        Mult. Scler. 2003; 9 ([online serial]. Mult SclerAccessed at) (Accessed April 27, 2022): 82-88
        • Kever A.
        • Leavitt V.M.
        Assessing diagnosis disclosure and concealment in multiple sclerosis: development and initial validation of the DISCO-MS survey.
        Mult. Scler. 2022; 28: 247-256
        • Kever A.
        • Riley C.S.
        • Leavitt V.M.
        Diagnosis concealment is associated with psychosocial outcomes in persons with multiple sclerosis.
        Mult. Scler. 2022; 28 (Accessed January 31, 2022): 1311-1314
        • Koopman W.
        • Schweitzer A.
        The journey to multiple sclerosis: a qualitative study.
        J. Neurosci. Nurs. 1999; 31: 17-26
        • Köpke S.
        • Kern S.
        • Ziemssen T.
        • et al.
        Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial.
        J. Neurol. Neurosurg. Psychiatry. 2014; 85 ([online serial]. J Neurol Neurosurg PsychiatryAccessed at:) (Accessed April 27, 2022): 411-418
        • Krupp L.B.
        • Alvarez L.A.
        • LaRocca N.G.
        • Scheinberg L.C.
        Fatigue in multiple sclerosis.
        Arch. Neurol. 1988; 45 ([online serial]Accessed at) (Accessed January 29, 2015): 435-437
        • Learmonth Y.C.
        • Motl R.W.
        • Sandroff B.M.
        • Pula J.H.
        • Cadavid D.
        Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis.
        BMC Neurol. 2013; (Epub)
        • Leavitt V.M.
        • Kever A.
        It's time to talk about disclosure and concealment in MS.
        Mult. Scler. Relat. Disord. 2022; 58 ([online serial]. Mult Scler Relat DisordAccessed at:) (Accessed January 31, 2022)103537
        • Marrie R.A.
        • Walld R.
        • Bolton J.M.
        • et al.
        Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data.
        BMC Res. Notes. 2017; 10 ([online serial]Accessed at:) (Accessed April 20, 2020): 619
        • O'Connor A.B.
        • Schwid S.R.
        • Herrmann D.N.
        • Markman J.D.
        • Dworkin R.H.
        Pain associated with multiple sclerosis: systematic review and proposed classification.
        Pain. 2008; 137 ([online serial]Accessed at:): 96-111
        • Solani A.
        • Aquarone N.
        • Pucci E.
        • et al.
        Communicating the diagnosis of multiple sclerosis - a qualitative study.
        Mult. Scler. 2007; 13 ([online serial]. Mult SclerAccessed at:) (Accessed April 27, 2022): 763-769
        • Solari A.
        • Martinelli V.
        • Trojano M.
        • et al.
        An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care.
        Mult. Scler. 2010; 16 ([online serial]. Mult SclerAccessed at:) (Accessed April 27, 2022): 1393-1405
        • Solari A.
        • Mattarozzi K.
        • Vignatelli L.
        • et al.
        Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis.
        Mult. Scler. 2010; 16 ([online serial]. Mult SclerAccessed at:) (Accessed April 27, 2022): 1237-1247
        • Solari A.
        • Mattarozzi K.
        • Vignatelli L.
        • et al.
        Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis.
        Mult. Scler. 2010; 16 ([online serial]. Mult SclerAccessed at:) (Accessed May 11, 2022): 1237-1247
        • Spencer L.
        • Silverman A.
        • Cook J.
        Adapting to multiple sclerosis stigma across the life span.
        Int. J. MS Care. 2019; 21 ([online serial]. Int J MS CareAccessed at:) (Accessed October 2, 2021): 227-234
        • Sumowski J.F.
        • Benedict R.
        • Enzinger C.
        • et al.
        Cognition in multiple sclerosis: state of the field and priorities for the future.
        Neurology. 2018; 90 (Lippincott Williams and Wilkins;): 278-288
        • Thomas P.W.
        • Thomas S.
        • Hillier C.
        • Galvin K.
        • Baker R.
        Psychological interventions for multiple sclerosis.
        Cochrane Database Syst. Rev. 2006; ([online serial]. Cochrane Database Syst Rev2006. Accessed at:) (Accessed April 27, 2022)
        • Thoolen B.
        • de Ridder D.
        • Bensing J.
        • Gorter K.
        • Rutten G.
        Beyond good intentions: the development and evaluation of a proactive self-management course for patients recently diagnosed with type 2 diabetes.
        Health Educ. Res. 2008; 23 ([online serial]. Health Educ ResAccessed at:) (Accessed August 23, 2021): 53-61
      1. Topcu G, Mhizha-Murira JR, Griffiths H, Bale C, Drummond A, Fitzsimmons D, Potter KJ, Evangelou N, das Nair R. Experiences of receiving a diagnosis of multiple sclerosis: a meta-synthesis of qualitative studies. Disabil Rehabil. 2022 Mar 7:1-12. doi: 10.1080/09638288.2022.2046187. Epub ahead of print. PMID: 35254195.